103 results
424B4
BIXT
Bioxytran, Inc
2 Oct 23
Prospectus supplement with pricing info
11:36am
:
the severity of the disease under investigation;
the patient eligibility criteria for the study in question;
the perceived risks and benefits … access to or educate physicians on the benefits of our products;
the lack of complementary products to be offered by sales personnel, which may put us
424B4
c4pnb248
14 Aug 23
Prospectus supplement with pricing info
8:07pm
8-K
EX-99.1
ucg18gay7pre3 ve5r
12 Jun 23
Entry into a Material Definitive Agreement
6:11am
8-K
EX-10.56
saebx okle1y02f
14 Nov 22
Entry into a Material Definitive Agreement
7:00am
8-K
shi7hti rlzn
14 Nov 22
Entry into a Material Definitive Agreement
7:00am